Ignite Creation Date:
2025-12-26 @ 4:01 PM
Ignite Modification Date:
2025-12-31 @ 9:30 PM
Study NCT ID:
NCT03057106
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-29
First Post:
2017-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
Sponsor:
Canadian Cancer Trials Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2017-02-15
First Submit QC Date:
None
Study First Post Date:
2017-02-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-05-11
Results First Submit QC Date:
None
Results First Post Date:
2022-02-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-11
Last Update Post Date:
2025-08-29
Last Update Post Date Type:
ESTIMATED